Cargando…
Impact of Non-Human Leukocyte Antigen-Specific Antibodies in Kidney and Heart Transplantation
The presence of donor human leukocyte antigen (HLA)-specific antibodies has been shown to be associated with graft loss and decreased patient survival, but it is not uncommon that donor-specific HLA antibodies are absent in patients with biopsy-proven antibody-mediated rejection. In this review, we...
Autores principales: | Zhang, Xiaohai, Reinsmoen, Nancy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389972/ https://www.ncbi.nlm.nih.gov/pubmed/28450866 http://dx.doi.org/10.3389/fimmu.2017.00434 |
Ejemplares similares
-
Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome
por: Molina, Juan, et al.
Publicado: (2017) -
Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies
por: Del Bello, Arnaud, et al.
Publicado: (2020) -
Immunological risk assessment and human leukocyte antigen antibody testing in kidney transplantation
por: Phanish, M. K.
Publicado: (2016) -
Cardiac Non-Human Leukocyte Antigen Identification: Techniques and Troubles
por: Gates, Katherine V., et al.
Publicado: (2017) -
Allele-specific quantification of human leukocyte antigen transcript isoforms by nanopore sequencing
por: Hughes, Andrew E. O., et al.
Publicado: (2023)